Hidden Scalp Inflammation May Be Causing Hair Loss Treatment Failures
Hidden Scalp Inflammation May Be the Culprit Behind Failing Hair Loss Treatments
A groundbreaking study has shed new light on a potential explanation for why some hair loss treatments fail to deliver desired results. Researchers at Dr. U Hair and Skin Clinic in Los Angeles have identified a previously unknown pattern of inflammation and early fibrosis around the upper part of the hair follicle, known as PIILIF.
Unlocking the Mystery Behind Failing Treatments
The study analyzed 129 patients with androgenetic alopecia (AGA), also known as male or female pattern baldness. The researchers found that PIILIF was present in normal-appearing scalp in 81% of patients, particularly those over 44 years old with advanced hair loss or prior poor response to treatment.
- PIILIF was more common among patients with severe hair loss or a history of poor response to treatment
- Inflammation and early fibrosis were often misdiagnosed as seborrheic dermatitis, a condition affecting the scalp that is relatively rare
- Treatment outcomes improved when addressing hormonal drivers and follicle-centered immunologic inflammation
According to Dr. Sanusi Umar, lead author of the study, "many hair loss sufferers do all the right things, including minoxidil, finasteride, and even hair transplantation, yet still experience disappointing outcomes." He emphasizes that identifying PIILIF may be key to understanding why some treatments fail.
Implications for Hair Loss Treatment and Transplant Planning
The study's findings have significant implications for the treatment of hair loss. The authors suggest that a dual-pathway strategy, addressing both hormonal drivers and follicle-centered immunologic inflammation, may be more effective than traditional treatments that focus solely on dihydrotestosterone (DHT) control.
- PIILIF is not just a secondary condition but an underlying factor contributing to hair loss
- Treating only the symptoms of AGA without addressing PIILIF may lead to poor outcomes and unpredictable results
- Long-term, steroid-sparing anti-inflammatory strategies are recommended when PIILIF is present
Translating Findings into Clinical Practice
The authors encourage clinicians to adopt structured screening and management pathways to recognize inflammatory-pattern AGA earlier and integrate dual-pathway, long-term management when indicated.
Individual results may vary. This information is for educational purposes only and does not provide medical advice. Consult a healthcare professional before making any decisions based on this content.Rubenhair Clinic - Hair Transplant in Latvia. Learn more about our hair transplant services.